Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000362771

Medchemexpress LLC Tri-GalNAc-DBCO | 2999748-27-3 | 100.0% | 1730.94 | 25 MG
SDP

Catalog No. 5000362771
Encompass_Preferred

Tri-GalNAc-DBCO is a synthetic ligand composed of three GalNAc units connected to DBCO. It acts as a ligand for the sialic acid-degrading protein receptor (ASGPR) and can be coupled with targeting proteins or small molecules to form GalNAc-LYTACs. Tri-GalNAc-DBCO specifically binds to ASGPR and, through receptor-mediated endocytosis, guides the coupled molecules to lysosomes for degradation.

  • Specifically binds to ASGPR, leading to receptor-mediated endocytosis and lysosomal degradation of coupled molecules.
  • Can be conjugated with various targeting proteins or small molecules to create GalNAc-LYTACs.
  • In vitro studies show it can be conjugated with anti-EGFR antibody, anti-HER2 antibody, and anti-PCSK9 antibody to form homogeneous conjugates capable of efficiently degrading membrane proteins.
  • Offered at 99.97% purity.

Catalog No. 50-003-62771 Supplier Medchemexpress LLC Supplier No. 25MGHY148476
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Tri-GalNAc-DBCO is a synthetic ligand composed of three GalNAc units connected to DBCO. It acts as a ligand for the sialic acid-degrading protein receptor (ASGPR) and can be coupled with targeting proteins or small molecules to form GalNAc-LYTACs. Tri-GalNAc-DBCO specifically binds to ASGPR and, through receptor-mediated endocytosis, guides the coupled molecules to lysosomes for degradation.

  • Specifically binds to ASGPR, leading to receptor-mediated endocytosis and lysosomal degradation of coupled molecules.
  • Can be conjugated with various targeting proteins or small molecules to create GalNAc-LYTACs.
  • In vitro studies show it can be conjugated with anti-EGFR antibody, anti-HER2 antibody, and anti-PCSK9 antibody to form homogeneous conjugates capable of efficiently degrading membrane proteins.
  • Offered at 99.97% purity.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.